Elevated Estrogen Receptor Expression in Human Prostatic Stromal Cells by Androgen Ablation Therapy

作者: Inge G. Kruithof-Dekker , Bernard Tetu , Patrick J.A. Janssen , Theodorus H. Van Der Kwast

DOI: 10.1016/S0022-5347(01)65749-5

关键词:

摘要: AbstractPurpose: The presence of estrogen receptors (ER) in human prostatic tissue is a longstanding, controversial issue. In few experimental animal models androgen deprivation was shown to be associated with spontaneous increased ER expression tissue. We intended study whether these observations also apply tissue.Materials and Methods: Estrogen receptor by stromal glandular cells studied immunohistochemistry prostatectomy specimens 21 patients prostate cancer, treated for 3 months luteinizing hormone-releasing hormone (LHRH) agonist flutamide. addition 2 estrogens were examined. For comparison, series 18 untreated patients.Results: blockade showed atrophic changes the gland as well basal cell hyperplasia, features characteristic this therapy. Although pr...

参考文章(23)
Alice C. Levine, Alexander Kirschenbaum, Michael Droller, J. Lester Gabrilove, Effect of the addition of estrogen to medical castration on prostatic size, symptoms, histology and serum prostate specific antigen in 4 men with benign prostatic hypertrophy. The Journal of Urology. ,vol. 146, pp. 790- 793 ,(1991) , 10.1016/S0022-5347(17)37922-3
V. Ravn, B. Bruun Rasmussen, L. Højholt, M. Barfoed, I. Heiberg, S.M. Thorpe, Reproducibility of subjective immunohistochemical estrogen- and progesterone receptor determination in human endometrium. Pathology Research and Practice. ,vol. 189, pp. 1015- 1022 ,(1993) , 10.1016/S0344-0338(11)80674-6
S. M. HARMAN, P. D. TSITOURAS, Reproductive Hormones in Aging Men. I. Measurement of Sex Steroids, Basal Luteinizing Hormone, and Leydig Cell Response to Human Chorionic Gonadotropin The Journal of Clinical Endocrinology and Metabolism. ,vol. 51, pp. 35- 40 ,(1980) , 10.1210/JCEM-51-1-35
Fernand Labrie, Lionel Cusan, José-Luis Gomez, Pierre Diamond, Raul Suburu, Martin Lemay, Bernard Tetu, Yves Fradet, Bernard Candas, Down-staging of early stage prostate cancer before radical prostatectomy: The first randomized trial of neoadjuvant combination therapy with flutamide and a luteinizing hormone-releasing hormone agonist Urology. ,vol. 44, pp. 29- 37 ,(1994) , 10.1016/S0090-4295(94)80241-6
Risto Santti, Sari Mäkelä, Liisa Pylkkänen, Retha R. Newbold, John A. McLachlan, Developmental estrogenization and prostatic neoplasia The Prostate. ,vol. 24, pp. 67- 78 ,(1994) , 10.1002/PROS.2990240204
U.-F. Habenicht, U.W. Tunn, Th. Senge, F.H. Schröder, H.U. Schweikert, G. Bartsch, M.F. El Etreby, Management of benign prostatic hyperplasia with particular emphasis on aromatase inhibitors. The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 44, pp. 557- 563 ,(1993) , 10.1016/0960-0760(93)90259-Y
Kazuhiro Suzuki, Yutaka Takezawa, Takanori Suzuki, Seijiro Honma, Hidetoshi Yamanaka, Synergistic effects of estrogen with androgen on the prostate--effects of estrogen on the prostate of androgen-administered rats and 5-alpha-reductase activity. The Prostate. ,vol. 25, pp. 169- 176 ,(1994) , 10.1002/PROS.2990250402
A. M. Nakhla, M. S. Khan, N. P. Romas, W. Rosner, Estradiol causes the rapid accumulation of cAMP in human prostate Proceedings of the National Academy of Sciences of the United States of America. ,vol. 91, pp. 5402- 5405 ,(1994) , 10.1073/PNAS.91.12.5402
H. J. De Voogt, B. R. Rao, A. A. Geldof, L. J. G. Gooren, F. G. Bouman, Androgen action blockade does not result in reduction in size but changes histology of the normal human prostate. The Prostate. ,vol. 11, pp. 305- 311 ,(1987) , 10.1002/PROS.2990110403